台耀化學股份有限公司 2025 Sustainability Report
Verified by a third party
-
Reporting Year:2025
-
Disclosure Period:2025/01/01 ~ 2025/12/31
-
Industry:生技醫療業
-
Verification Agency:法標國際認證股份有限公司 (AFNOR Asia Ltd)
-
Verification Standards:主要依循全球報告倡議組織 GRI 準則 2021 年版,並揭露 SASB 生物科技與製藥業準則指標、TCFD 氣候相關財務揭露建議,以及參考 IFRS S1/S2 永續揭露準則。
Report summary
- This page summarizes the 2025 sustainability report and ESG report PDF source for 台耀化學股份有限公司 (4746).
- The reporting period is 2025/01/01 to 2025/12/31, in the 生技醫療業 industry.
- third-party information includes verification body 法標國際認證股份有限公司 (AFNOR Asia Ltd); this can be used to review report verification, assurance, and disclosure standards.
- Compare public disclosure approaches across prior-year and peer reports. Your company’s actual disclosures must still be based on its own data and supporting evidence.
Report details
- Company
- 台耀化學股份有限公司(4746)
- Reporting Year
- 2025
- Disclosure Period
- 2025/01/01 to 2025/12/31
- Industry
- 生技醫療業
- Third-party information
- third-party information includes verification body 法標國際認證股份有限公司 (AFNOR Asia Ltd)
- PDF source
- The original ESG report PDF can be downloaded or opened from this page
2025 ESG Metrics and Industry Comparison
Greenhouse Gas Emissions
- Scope 1 Emissions (Tons CO2e)
- 9,029
- Reporting Boundary:已完成母公司
- Verification:否
- Scope 2 Emissions (Tons CO2e)
- 26,238
- Reporting Boundary:已完成母公司
- Verification:否
- Scope 3 Emissions (Tons CO2e)
- 21,449
- Reporting Boundary:已完成母公司
- Verification:否
Energy Management
- Renewable Energy Share
- 1%
- Reporting Boundary:母公司 (涵蓋台耀總公司辦公場所、蘆竹廠及蘆竹二廠全區範圍)
- Verification:Not disclosed
- Ranked 7 among 15 companies in the same industry (percentile 57).
Water Management
- Water Use (Metric Tons)
- 524,091
- Reporting Boundary:母公司 (涵蓋台耀化學股份有限公司個體,包含蘆竹廠及蘆竹二廠,不包含子公司資訊)
- Verification:Not disclosed
Board of Directors
- Board Seats (Including Independent Directors)
- 9
- Independent Director Seats
- 4
- Female Director Ratio
- 22.2%
- Ranked 25 among 61 companies in the same industry (percentile 42).
- Board Meeting Attendance Rate
- 100%
- Ranked 1 among 61 companies in the same industry (percentile 75).
- Independent Director Ratio
- 44.4%
- Ranked 16 among 61 companies in the same industry (percentile 62).
Source: Taiwan Stock Exchange / Taipei Exchange, Corporate ESG Disclosure Summary (2025), under the Open Government Data License, version 1.0. Open Government Data License, Version 1.0
How to use this report
- Compare how 台耀化學股份有限公司 structured 生技醫療業 sustainability report chapters and material topics in 2025.
- Confirm the reporting period, third-party verification or assurance information, and downloadable ESG report PDF source.
- Mark public disclosures and original page numbers that can be referenced as research materials for planning chapters and indicators for your own company.
Reports from the Same Industry
-
Download report
大江生醫股份有限公司
2025 Sustainability Report
-
Download report
合一生技股份有限公司
2025 Sustainability Report
-
Download report
中天生物科技股份有限公司
2025 Sustainability Report
-
Download report
威力德生醫股份有限公司
2025 Sustainability Report
-
Download report
東生華製藥股份有限公司
2025 Sustainability Report
-
Download report
台灣東洋藥品工業股份有限公司
2025 Sustainability Report
-
Download report
醫揚科技股份有限公司
2025 Sustainability Report
-
Download report
佳醫健康事業股份有限公司
2025 Sustainability Report
-
Download report
大學光學科技股份有限公司
2025 Sustainability Report
-
Download report
久裕企業股份有限公司
2025 Sustainability Report
